Approved for use in the United States
When will approval of ORTHOVISC be completed?
A highly purified, high molecular weight, high viscosity injectable form of hyaluronic acid (HA) intended to relieve pain and to improve joint mobility and range of motion in patients suffering from osteoarthritis (OA) of the knee. Currently, ORTHOVISC, a brand of sodium hyaluronate is not approved for use in the United States, but it is marketed and sold in Canada, Europe and other countries. ORTHOVISC is a localized injectable treatment for osteoarthritis of the knee which is an alternative to other injectable or oral treatments. ORTHOVISC is injected into the knee to restore the elasticity and viscosity of the synovial fluid.